| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $26.48B | +1.7% |
| Cost of Revenue | $18.36B | +5.8% |
| Gross Profit | $8.12B | -6.5% |
| R&D Expense | $127.0M | -9.3% |
| SG&A Expense | $4.49B | -14.1% |
| Operating Income | $3.63B | +5.0% |
| Interest Expense | $921.0M | -55.0% |
| Pre-tax Income | $2.97B | +73.7% |
| Income Tax | $598.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.04B | -69.8% |
| Accounts Receivable | $2.12B | +8.3% |
| Inventory | $3.65B | +33.8% |
| Current Assets | $7.90B | -12.2% |
| Total Assets | $90.51B | -3.1% |
| Current Liabilities | $9.03B | -0.4% |
| Long-term Debt | $19.23B | -8.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.47B | -54.0% |
| Capital Expenditures | $916.0M | +1.2% |
| Investing Cash Flow | -$1.09B | -127.0% |
| Financing Cash Flow | -$3.71B | +60.3% |
| Free Cash Flow | $1.55B | -65.2% |
| -12.6% |
| Net Income | $2.36B | +133.5% |
| EPS (Basic) | $1.93 | +132.5% |
| EPS (Diluted) | $1.91 | +132.9% |
| Total Liabilities |
| $41.64B |
| -5.2% |
| Stockholders' Equity | $48.68B | -1.3% |